Kanker kolon stadium 4 Dokter Terbaik di Istambul - TOP-18 dokter

Penulis dari lebih dari 40 publikasi yang ditinjau sejawat dalam biologi tumor/imunologi dan terapi sistemik (imunoterapi dan terapi terarah); anggota dari Asosiasi Onkologi Medis Turki dan European Head & Neck Society.

Alasan pasien memilih Dr. Bülent Karagöz:

• Perawatan berdasarkan protokol AS melalui kolaborasi strategis Anadolu Medical Center dengan institusi terkemuka AS — Johns Hopkins Medicine.
• Lebih dari 40 publikasi ilmiah dalam biologi/imunologi tumor dan terapi sistemik (imunoterapi dan terapi terarah).
• Mantan kepala departemen (GATA) dan profesor/ketua departemen (Universitas Okan, Turki) — kepemimpinan dan pengalaman klinis di pusat-pusat besar.
• Menangani tumor padat (misalnya, payudara, paru-paru, kolorektal), menerapkan rejimen modern yang dipandu oleh biologi tumor.
• Anadolu Medical Center memiliki penunjukan ESMO dan akreditasi JCI — artinya dokter merawat sesuai protokol internasional, dalam tim multidisiplin, dengan pengawasan ketat terhadap keselamatan.

Dia telah bekerja sebagai dokter spesialis penyakit dalam dan spesialis onkologi medis di Pusat Medis Anadolu sejak tahun 2021.
 

Assoc. Prof. Dr. Abdulcabbar Kartal is a distinguished colorectal and general surgeon practicing at Anadolu Medical Center in Istanbul. With over 17 years of surgical experience, he specializes in colorectal surgery, HIPEC (hyperthermic intraperitoneal chemotherapy) for peritoneal cancers, bariatric surgery, and minimally invasive procedures.

Dr. Kartal graduated from Istanbul University Faculty of Medicine in 2007 and completed his general surgery specialization at Istanbul Şişli Etfal Training and Research Hospital (2007-2013). He served as Assistant Professor at Istanbul Okan University (2016-2020) before receiving his Associate Professor title in 2020. In 2021, he earned the prestigious FEBS-C certification from the European Society of Coloproctology and became a Fellow of the American College of Surgeons (FACS).

Dr. Kartal has published over 40 articles in international peer-reviewed journals and is an active member of the Turkish Society of Colon and Rectal Surgery, European Society of Coloproctology, and Turkish Surgical Association.

Prof. Hüseyin Baloğlu is a pathology specialist at Anadolu Medical Center in Gebze, Kocaeli, Turkey. He focuses on molecular pathology, surgical pathology, and tumour biopsy and diagnostics.

Education and accreditations: MD, GATA Medical School (1986). Pathology specialty training, GATA (1992). Associate Professor (Doçent), GATA (2004). Visiting scholar at Albert Einstein College of Medicine (New York) and Heidelberg University.

Achievements: author of over 600 peer‑reviewed publications. Holds a patent in molecular diagnostics for thyroid cancer. Leads liquid biopsy and precision oncology services.

Dr. Sinan Karaaslan — Dokter Onkologi Medis di Anadolu Medical Center (sejak 2014). Ia menangani kanker payudara, kolorektal, dan genitourinari; dalam onkologi medis sejak 2003. Anggota dari Asosiasi Medis Turki, Masyarakat Onkologi Medis Turki, dan Masyarakat Kanker Paru-Paru Turki.

Mengapa pasien memilih dan mempercayai Dr. Karaaslan:

• Menangani kasus kanker payudara, kolorektal, dan genitourinari yang kompleks — menerapkan terapi sistemik modern yang disesuaikan dengan tipe dan stadium tumor.
• Anggota dari Asosiasi Medis Turki, Masyarakat Onkologi Medis Turki, dan Masyarakat Kanker Paru-Paru Turki.
• Penulis dari banyak artikel yang telah ditinjau sejawat dan materi edukasi pasien tentang kemoterapi dan imunoterapi.
• Bekerja di pusat dengan status ESMO Designated Centre dan akreditasi JCI, dalam kolaborasi strategis dengan Johns Hopkins Medicine International — salah satu institusi medis terkemuka di AS. Bagi pasien, ini berarti perawatan yang sesuai dengan protokol AS dan penggunaan peralatan canggih.

Profesor Yıldırım telah menerbitkan lebih dari 80 karya ilmiah dan merupakan spesialis dalam imunoterapi kanker serta terapi target di Pusat Medis Anadolu.

• Memiliki gelar profesor dari Universitas Halic dan merupakan dosen aktif
• Diotorisasi oleh ESMO – salah satu badan onkologi terkemuka di Eropa
• Menjalani pelatihan persekutuan di klinik imunoterapi di London dan Israel
• Memiliki pengalaman lebih dari 21 tahun sebagai spesialis onkologi medis

Prof. Şeref Kömürcü adalah seorang dokter onkologi medis dan payudara bersertifikat ECFMG dan ESMO dengan pengalaman lebih dari 20 tahun. Beliau berspesialisasi dalam pengobatan kanker padat, kanker payudara, kanker kolorektal, dan kanker paru-paru serta telah memegang posisi pengajaran dan ilmiah sepanjang kariernya. Beliau adalah anggota dari beberapa organisasi profesional.

Dr. Vafi Atalay adalah seorang ahli bedah onkologi dan bedah umum berpengalaman dengan 17 tahun di bidang ini. Ia berspesialisasi dalam pembedahan pankreas, kolon, rektum, dan hati. Ia juga melakukan prosedur endoskopi lanjut. Dr. Atalay telah menerbitkan 31 artikel di jurnal nasional dan internasional, yang memberikan kontribusi berharga bagi literatur medis.

Ia meraih hadiah pertama di Kompetisi Makalah Penelitian Kongres ke-20. Ia juga memenangkan Penghargaan Penelitian Terbaik di Kongres Penelitian Ahli Bedah ke-5. Dr. Atalay adalah anggota TSS, Asosiasi Medis Palestina, dan IOA. Keterlibatan aktifnya dalam organisasi-organisasi ini menunjukkan dedikasinya terhadap pertumbuhan profesional dan keunggulan bedah.

Spesialis Dr. Rahib Hasanov memadukan pelatihan internasional dengan perawatan onkologi yang dipersonalisasi, dengan fokus pada kasus kanker kolon stadium lanjut.

• Menjalani pelatihan di Houston Methodist Hospital, AS
• Spesialisasi dalam imunoterapi dan terapi target
• Fellowship di bidang Onkologi Medis dari Universitas Marmara
• Menangani pasien dari berbagai negara
• Mengintegrasikan obat pintar terbaru ke dalam perawatan

Dr. Mehmet Doğu Canoğlu is a radiation oncologist. He graduated from Kocaeli University Faculty of Medicine. He completed his residency in radiation oncology at Kocaeli University from 2006 to 2012.

He completed his compulsory service at Diyarbakır Training and Research Hospital. He then worked at Bağcılar Training and Research Hospital and at Medipol Mega University Hospital from 2015 to 2017. Since 2017, he has been a radiation oncologist at Anadolu Medical Center.

Dr. Saban Sec berspesialisasi dalam kanker gastrointestinal, dengan fokus penelitian pada prognosis dan hasil pengobatan kanker kolon.

• Spesialis onkologi medis dengan fokus pada kanker kolon, rektum, dan lambung
• Penelitian yang dipublikasikan mengenai dampak lokalisasi tumor terhadap keberlangsungan hidup pasien kanker kolon
• Anggota Asosiasi Onkologi Medis Turki

Assoc. Prof. Atakan Topçu, M.D., is a medical oncologist at Medipol University and Medipol Acıbadem Regional Hospital. He treats solid tumors, including lung, breast, colorectal, gastric, and neuroendocrine cancers. His work also covers targeted therapies, immunotherapy, geriatric oncology, and cancer-related malnutrition, cachexia, and sarcopenia.

He has authored more than 50 peer-reviewed papers. Recent work includes a 2024 Frontiers in Medicine study on geriatric syndromes and a 2023 Future Oncology paper on sarcopenia and anxiety in lung cancer. He has also published on the CONUT score in breast cancer and on malnutrition in HER2-negative metastatic gastric cancer.

Dr. Topçu serves on the Editorial Board of BMC Cancer. He is a member of the Turkish Society of Medical Oncology, ESMO, and the Turkish Geriatrics Society. Education and training: M.D., Uludağ University; residency in Internal Medicine, Marmara University; fellowship in Medical Oncology, Bezmialem Vakıf University.

Dr. Irfan Cicin is a Professor of Medical Oncology at the Trakya University Faculty of Medicine (2015–present). He has over 20 years of medical oncology experience and has held academic roles since 2010.

Education: MD, Istanbul University – Cerrahpaşa (1991–1997). Residency in Internal Medicine, Trakya University (1997–2002). Fellowship in Medical Oncology, Trakya University (2002–2004).

Practice: Medical Oncologist, Trakya University (2005–2008). Medical Oncologist, Elazığ Training and Research Hospital (2008–2010). Associate Professor of Medical Oncology, Trakya University (2010–2015). He previously served as a physician in the Turkish Air Force at Etimesgut Military Hospital (2004–2005).

Dr. Ozden berspesialisasi dalam kanker kolon stadium 4 dengan pengalaman luas di bidang onkologi medis.

• Lulus dari Program Medis Bahasa Inggris Universitas Istanbul
• Menyelesaikan residensi Penyakit Dalam di Fakultas Kedokteran Cerrahpaşa
• Subspesialisasi dalam Onkologi Medis di Universitas Kocaeli
• Praktik di Rumah Sakit Umum Şırnak dan Rumah Sakit Swasta Safa Bağcılar

Assoc. Prof. Ayşe İrem Yasin, M.D., is a medical oncologist who specializes in solid tumors. Her clinical focus includes breast, lung, gastrointestinal, gynecologic, and urologic cancers. She also treats brain and other CNS tumors, soft tissue sarcomas, head and neck cancers, adenocarcinomas, melanoma, Merkel cell carcinoma, and cancers of unknown primary. She practices at Medipol Acıbadem District Hospital (2025–present). She previously worked at Şişli Etfal Training and Research Hospital (2023–2025).

She completed a Medical Oncology fellowship at Bezmialem Vakıf University (2019–2022). This followed an Internal Medicine residency at the same institution (2012–2016). Her international experience includes the Breast Cancer Unit at the University of Piemonte Orientale in Novara (2022). She also trained at Basel University Hospital, Cleveland Clinic, and Harvard Medical School. She holds the ESMO Board Certificate (2022).

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).

He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.

Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.

Spesialis dalam bedah onkologi laparoskopi dan robotik untuk kanker kolon dan rektum dengan pelatihan internasional di lembaga-lembaga terkemuka.

• Melakukan bedah hernia laparoskopi dan menangani penyakit anorektal yang kompleks
• Menjalani pelatihan di University of Colorado Health Science Center dan USC Keck School of Medicine
• Fellow dari European Board of Surgery – Emergency Surgery
• Associate Professor Bedah Umum di Fakultas Kedokteran Istanbul